Today, conducting good clinical trials in hematological malignancies requires an understanding of a rapidly evolving treatment paradigm that is increasingly nuanced, complex and patient-directed. Sponsors developing hematological oncology therapies must capitalize on the principles and infrastructures shared by solid tumor oncology trials while adapting endpoints, study designs and data management as well as considering patients’ experiences to address the particular challenges related to investigating candidate treatments for blood-based cancers. This paper examines the nuances of effectively and successfully conducting hematological oncology clinical trials.
While the use of electronic patient reported outcomes (ePROs) is becoming widespread, a mentality still exists for paper being the “gold-standard” when it comes to trial questionnaire design.
But moving beyond a “paper mindset” offers new pools of data sources, creates new ways of running studies, and significantly impacts the way clinical trials are run.
In this illustrated eBook, CRF Health provides new and unique perspectives on electronic questionnaire design.
This White Paper presents the case for a new data-driven paradigm in clinical research in which multiple data points are viewed holistically, delivering real-time oversight of investigative sites, studies, and programs for improved trial management.
The need to save money in clinical research is universal. The ability to identify ways to increase efficiency and reduce costs throughout the clinical trial lifecycle often spells the difference between successful companies and also-rans. This article explores ten proven strategies for reducing costs, from study design to data management
Cancer genomics is moving into practice, driven by improved understanding of molecular heterogeneity within cancers and increased availability of drugs that target genomic alterations. Evaluating biomarker-targeted cancer therapies with companion diagnostics is essential to contemporary oncology drug development strategies.
This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.
At Q2 Solutions, we support infectious disease clinical trials with a variety of tools. Learn how we are applying the latest technologies to provide insights for developing diagnostics and therapies with enhanced efficacy.
inVentiv Health experts offer advice on how to follow the regulatory pathway most expeditiously, and highlight examples that illustrate both the advantages and challenges of pursuing Accelerated Approval.
In the white paper, industry leaders Validic, Biogen and Medidata discuss how digital health is poised to disrupt the pharmaceutical industry and revolutionize the clinical trial process and medication adherence. Download this free white paper today to learn more about identifying the potential digital health has in the pharmaceutical industry, the real-world value of digital health data and early victories of digital health.
This paper addresses the ever-increasing volume of clinical data and the importance of a biovisualization platform to enable effective data mining. By diversifying data visualization, researchers can better identify important trends.
Electronic Data Capture (EDC) and digital communications are no longer considered novelties in clinical research. Besides improving data management and adherence to study protocols, the right EDC product can help improve delegation, reduce conflict and increase satisfaction in your organization.